OUR VISION is to be the world’s leader in nanosensor-based, point-of-care diagnostics for a wide variety of diseases including Covid-19, Traumatic Brain Injury (TBI), Sepsis and Stroke.

OUR VALUES include holding ourselves to the highest quality standards, driving to be the best in the industry, both individually and collectively, and having the highest levels of integrity and ethical behavior.

1945 – 2021

In memory of our dear friend and colleague Bob Mercier. Bob was instrumental in the initial launch of BioDirection® (now NanoDx™) over 11 years ago and joined our Board of Directors when it was formed in 2012. Bob was a committed, hardworking member of the NanoDx team. His unique capability of considering diverse opinions to arrive at optimal outcomes was an invaluable asset to our Board and company. Bob was a terrific guy who loved fishing, card games, and spending time with his family. Bob will be forever missed by us all.

Board of


James A. Wylie
Executive Chairman
Mr. Wylie is a proven business leader with 35 years of executive management experience in emerging and global businesses. He has held leadership positions as a general manager, division president, group executive and chief executive officer in both public and private sector companies including IMC, Albany International, Uniroyal, EcoScience and Diomed Holdings. Additionally, Mr. Wylie spent nine years providing strategic advisory and interim CEO services to institutional investors across a broad range of markets and technologies. His market and product line experience includes biotechnology, medical devices, diagnostics and medical service equipment, mobile wireless data communication, commodity and specialty chemicals, polymers, crop protection, and waste management equipment and services. Mr. Wylie has extensive experience in public and private financing, mergers and acquisitions, joint ventures, strategic alliances, state and federal regulatory affairs, legislative lobbying, media relations, and global operations. He has served on 9 Boards, stimulating change and driving corporate growth. Mr. Wylie holds a B.S. in Chemistry from Bates College and served on active duty as a Lieutenant in the US Navy Reserve. (Full Corporate and Executive management background available upon request.)Read More
Sharad Joshi
President & CEO
Sharad Joshi is a global entrepreneurial medical devices CEO with a strong track record driving rapid global growth and laying the strategic foundations for sustained success through strategic and product innovation, proven sales/marketing and distribution channel building, and M&A/partnership/alliance leadership. He is a leader who fosters a mission-focused, fun and collaborative environment. Builds and leads makeovers of scalable management teams and organizations, while drawing future-critical next generation talent.Read More
Stephen Brackett
Board Member, Chairman of Sports Advisory Board
Steve Brackett, has 34 years of experience in the financial services industry primarily focused on private equity and venture capital investing, fund development and operational management, investment banking, and structured finance. Steve is President, Managing Member and Co-Head of Alternative Investments, and a member of the Management and Investment Committees at Shepherd Kaplan Krochuk, LLC, a $6 Billion investment management and advisory firm headquartered in Boston, MA. Steve is directly involved in the management and development of the alternative investment initiatives at the company, which includes product development, transaction origination, capital formation, portfolio construction, due diligence across investment and operation functions, strategic initiative development and management, and divisional governance. Steve also oversees operational management for the direct investment division of the firm.Read More
Jean-Luc Boulnois
Ph.D., M.Sc., EMBA
Board Member
With over 30 years of global leadership in the medical device industry, Dr. Boulnois has developed early-stage companies, participated in an Initial Public Offering, and led several mergers, acquisitions, licensing transactions, and financing rounds. His strong operational experience in multiple medical specialties (cardiovascular, general surgery, urology, neurosurgery) and deep relationships throughout industry, enabled him to focus on managing high growth opportunities, through innovation, unique business models, international expansion, or strategic acquisitions. Dr. Boulnois is President and CEO of Quadrature, a Boston-based strategic advisory firm for MedTech companies with a focus on early-stage and mid-market enterprises.Read More
Brian McGlynn
Founder, Executive Vice President, Chief Technical Officer
Mr. McGlynn has been a part of the medical device industry for over 30 years. His experience includes 3.5 years of surgical experience (U.S. Surgical) and product development in Orthopedics and Cardiovascular medicine. Mr. McGlynn began his career in cardiovascular products working with Bentley to produce tubing packs and oxygenators for open-heart procedures and working to build the team of investigators for the St Jude prosthetic heart valve. Prior to BioDirection Mr. McGlynn has consulted with clients from several industries helping them to recognize the needs of the marketplace and succeed in a global market. Mr. McGlynn holds a Bachelor of Science degree in Business Administration from Trinity University following Premed studies at the University of Wisconsin, Milwaukee.Read More
Brian Lockhart
Board Member
Mr. Lockhart is an owner and a member of the Management Board of Shepherd Kaplan Krochuk. He is the founder, Chief Executive Officer and Chief Investment Officer of Peak Capital Management, LLC (PCM), which SKK acquired in February 2020. With over 25 years of portfolio management experience, he serves as the co-portfolio manager of PCM’s suite of proprietary strategies, directing the company’s dynamic allocation of distinguished ETF investment strategies implemented on behalf of high net worth and institutional clients. Brian has been featured in multiple media outlets including Barron’s, Forbes, Fortune and Business Week. He is an active conference speaker, presenting on topics such as portfolio and risk management and alternative investments. Brian received a Bachelor of Science in Business Administration from California Polytechnic State University in San Luis Obispo, California. Brian was also awarded a certificate for completion of the Investment Decisions and Behavioral Finance Program (11/2017), at John F. Kennedy School of Government at Harvard University, Executive Education.Read More

NanoDx is always searching for new opportunities. Contact us today with any questions or inquiries.

Contact Us